UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

American journal of transplantation, 2010-05, Vol.10 (5), p.1228-1237

2010

Link zum Volltext

Verfügbarkeit prüfen

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

American journal of transplantation, 2007-09, Vol.7 (9), p.2106-2113

2007

Link zum Volltext

Verfügbarkeit prüfen

Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study

American journal of transplantation, 2005-12, Vol.5 (12), p.2929-2936

2005

Link zum Volltext

Verfügbarkeit prüfen

Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging

Kidney international, 2006-05, Vol.69 (10), p.1839-1845

2006

Link zum Volltext

Verfügbarkeit prüfen

Safe central venous catheter insertion practice must extend beyond simply measuring catheter-associated bloodstream infections

The Journal of hospital infection, 2015-05, Vol.90 (1), p.81-81

2015

Link zum Volltext

Verfügbarkeit prüfen

Analysis and clinical correlation of genetic variation in cytomegalovirus

Transplant infectious disease, 2012-04, Vol.14 (2), p.132-140

2012

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy

The Lancet (British edition), 1995-06, Vol.345 (8964), p.1540-1542

1995

Link zum Volltext

Verfügbarkeit prüfen

High cholesterol absorption is associated with increased cardiovascular risk in hemodialysis patients: Insights from the AURORA study

Atherosclerosis, 2022-08, Vol.355, p.14

2022

Link zum Volltext

Verfügbarkeit prüfen

Long‐Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

American journal of transplantation, 2009-05, Vol.9 (5), p.1205-1213

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

The Lancet (British edition), 2003-06, Vol.361 (9374), p.2024-2031

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients

American journal of transplantation, 2010-08, Vol.10 (8), p.1881-1888

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Cardiovascular Screening in Potential Renal Transplant Recipients: A Single‐Center Prospective Observational Study

American journal of transplantation, 2008-08, Vol.8 (8), p.1673-1683

2008

Link zum Volltext

Verfügbarkeit prüfen

Renal Dysfunction Is a Strong and Independent Risk Factor for Mortality and Cardiovascular Complications in Renal Transplantation

American journal of transplantation, 2005-08, Vol.5 (8), p.1986-1991

2005

Link zum Volltext

Verfügbarkeit prüfen

Secreted Wnt Antagonists During Eradication of Cytomegalovirus Infection in Solid Organ Transplant Recipients

American journal of transplantation, 2014-01, Vol.14 (1), p.210-215

2014

Link zum Volltext

Verfügbarkeit prüfen

NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients

European heart journal open, 2022-11, Vol.2 (6), p.oeac069-oeac069

2022

Link zum Volltext

Verfügbarkeit prüfen

B-type natriuretic peptide predicts long-term survival after major non-cardiac surgery

British journal of anaesthesia : BJA, 2011-08, Vol.107 (2), p.144-149

2011

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial

Transplantation, 2005-01, Vol.79 (2), p.205

2005

Link zum Volltext

Verfügbarkeit prüfen

Serum phosphate and outcome at one year after deceased donor renal transplantation

Clinical transplantation, 2011-03, Vol.25 (2), p.E199-E204

2011

Link zum Volltext

Verfügbarkeit prüfen

Response to Letter About Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease

American journal of transplantation, 2011-05, Vol.11 (5), p.1103-1104

2011

Link zum Volltext

Verfügbarkeit prüfen

Vascular function in patients with end-stage renal disease and/or coronary artery disease: A cardiac magnetic resonance imaging study

Kidney international, 2007-01, Vol.71 (1), p.68-73

2007

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Magnetic Resonance Imaging Has Much to Offer in the Assessment of Renal Transplant Recipients

American journal of transplantation, 2006-08, Vol.6 (8), p.1975-1976

2006

Link zum Volltext

Verfügbarkeit prüfen

Endothelial Dysfunction in Renal Transplant Recipients

Transplantation proceedings, 2005-11, Vol.37 (9), p.3805-3807

2005

Link zum Volltext

Verfügbarkeit prüfen

A Simulation Model to Investigate the Impact of Cardiovascular Risk in Renal Transplantation

Transplantation proceedings, 2005-06, Vol.37 (5), p.2135-2143

2005

Link zum Volltext

Verfügbarkeit prüfen

Dolly, no longer the exception: telomeres and implications for transplantation

Cloning and stem cells, 2003-01, Vol.5 (2), p.157

2003

Link zum Volltext

Verfügbarkeit prüfen

Circulating Endothelial Cells in Renal Transplant Recipients

Transplantation proceedings, 2005-06, Vol.37 (5), p.2387-2390

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(28)
Humans
(27)
Female
(20)
Male
(20)
Transplantation
(20)
Surgery
(19)
Middle Aged
(18)
Adult
(15)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(12)
Risk Factors
(9)
Immunology
(8)
Aged
(7)
Cytomegalovirus
(6)
Kidney Transplantation
(6)
Cytomegalovirus Infections - Drug Therapy
(5)
Ganciclovir - Analogs & Derivatives
(5)
Immunosuppressive Agents - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study

Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging

Safe central venous catheter insertion practice must extend beyond simply measuring catheter-associated bloodstream infections

Analysis and clinical correlation of genetic variation in cytomegalovirus

Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy

High cholesterol absorption is associated with increased cardiovascular risk in hemodialysis patients: Insights from the AURORA study

Long‐Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients

Prognostic Value of Cardiovascular Screening in Potential Renal Transplant Recipients: A Single‐Center Prospective Observational Study

Renal Dysfunction Is a Strong and Independent Risk Factor for Mortality and Cardiovascular Complications in Renal Transplantation

Secreted Wnt Antagonists During Eradication of Cytomegalovirus Infection in Solid Organ Transplant Recipients

NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients

B-type natriuretic peptide predicts long-term survival after major non-cardiac surgery

Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial

Serum phosphate and outcome at one year after deceased donor renal transplantation

Response to Letter About Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease

Vascular function in patients with end-stage renal disease and/or coronary artery disease: A cardiac magnetic resonance imaging study

Cardiovascular Magnetic Resonance Imaging Has Much to Offer in the Assessment of Renal Transplant Recipients

Endothelial Dysfunction in Renal Transplant Recipients

A Simulation Model to Investigate the Impact of Cardiovascular Risk in Renal Transplantation

Dolly, no longer the exception: telomeres and implications for transplantation

Circulating Endothelial Cells in Renal Transplant Recipients

Suchergebnisse filtern